French health insurance startup Alan<\/strong> has reached a valuation of \u20ac5 billion<\/strong> (about $5.83 billion) after a new \u20ac100 million ($116 million) financing round. Founded in 2016, the company has built a modern health-insurance platform and is now accelerating product development, international expansion and investments in technology and AI \ud83e\udd16.<\/p>\n The \u20ac100M round was led by existing investor Index Ventures<\/strong> and included new backers such as Greenoaks<\/strong>, Kaaf<\/strong> and SH<\/strong>, plus business angels like Shopify founder Tobi L\u00fctke<\/strong> and footballer Antoine Griezmann<\/strong>. Belgian bank-insurer Belfius<\/strong>, a strategic partner that led Alan\u2019s prior Series F, also participated.<\/p>\n Alan offers a mobile-first app where users can manage reimbursements, access doctors and track health habits. Since launching, the company has scaled to roughly 740 employees and covers about one million people across corporates, freelancers and retirees.<\/p>\n Revenue momentum is strong: Alan reported \u20ac785M in ARR for 2025<\/strong>, a 53% increase from the end of 2024. That growth underpins the new valuation and the company\u2019s plan to keep investing in product and engineering \ud83d\udcc8.<\/p>\n Alan says it has reached operational profitability in France<\/strong>, its largest market, and is approaching operating break-even overall. The company recorded net losses of $61M in 2023 and $56M in 2024, but it reports having halved losses as a percentage of revenue<\/em> over the past 12 months \u2014 a sign of improving unit economics.<\/p>\n Beyond France (where Alan was the first new independent insurer to be licensed since the 1980s), the company has expanded into Belgium and Spain \u2014 counting clients such as HP and Volkswagen \u2014 and has recently launched in Canada, now licensed across all provinces and beginning commercial operations \ud83c\udf0d.<\/p>\n Alan also won a public contract to insure up to 135,000 civil servants and their relatives<\/strong>, adding scale and diversification to its client base.<\/p>\n Alan plans to keep prioritizing international expansion and product improvements over immediate full profitability. It recently signaled a target of $1.16 billion in ARR for 2026<\/strong> rather than focusing solely on short-term profit \u2014 a trade-off many growth-stage investors accept when topline expansion and market share gains look promising.<\/p>\n Alan\u2019s new \u20ac5B valuation reflects investor confidence in its expansion strategy, product-led growth and improving profitability metrics. For the insurtech, the next 12\u201324 months will be critical as it scales overseas, deepens product capabilities and works to convert momentum into long-term financial sustainability \ud83e\ude7a\ud83d\ude80.<\/p>\n","protected":false},"excerpt":{"rendered":" Alan hits a \u20ac5 billion valuation after a \u20ac100M funding round \ud83d\udcb6. The French health insurtech is growing revenue fast, expanding internationally, and investing in tech and AI \u2014 here\u2019s what that means for its future \ud83d\udcc8\ud83e\ude7a\ud83c\udf0d.<\/p>\n","protected":false},"author":1,"featured_media":293,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-290","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-tech-news"},"yoast_head":"\nFast facts<\/h3>\n
\n
Funding round and investors<\/h3>\n
Products, reach and growth<\/h3>\n
Profitability and financial trends<\/h3>\n
Global expansion<\/h3>\n
Strategy: growth over near-term profits<\/h3>\n
What to watch next<\/h3>\n
\n